Literature DB >> 2931100

Langerhans' cells and lymphocyte subsets in the female genital tract.

J N Edwards, H B Morris.   

Abstract

Cryostat sections of healthy cervical, vaginal and vulval epithelium were examined using immunohistological labelling techniques and a panel of monoclonal antibodies recognizing Langerhans' cells, T- and B-lymphocytes and HLA-DR antigen. The distribution of Langerhans' cells in squamous epithelium of the cervix, vagina and vulva showed a marked variation with the highest median values in the vulva (18.7 per 100 basal squamous cells) and the lowest in the vagina (5.5 per 100 basal squamous cells). There was also a substantial variation in number and distribution of lymphocytes of each of these three areas with a distinct preponderance in the transformation zone of the cervix. In addition, intraepithelial lymphocytes, predominantly of the T-cytotoxic suppressor sub-type were present at all sites with the greatest number in the transformation zone. We conclude from this study that lymphoid tissue of the cervical transformation zone has several unique characteristics which are not observed at other sites in the lower genital tract. We suggest that this tissue be designated 'cervical lymphoid tissue' and that it forms a part of the 'mucosal associated lymphoid tissue' (MALT) as noted at other mucosal sites exposed to the external environment.

Mesh:

Substances:

Year:  1985        PMID: 2931100     DOI: 10.1111/j.1471-0528.1985.tb03080.x

Source DB:  PubMed          Journal:  Br J Obstet Gynaecol        ISSN: 0306-5456


  31 in total

1.  Density and distribution of Langerhans cells in the human uterine cervix.

Authors:  A E Morelli; G di Paola; L Fainboim
Journal:  Arch Gynecol Obstet       Date:  1992       Impact factor: 2.344

Review 2.  Targeting early infection to prevent HIV-1 mucosal transmission.

Authors:  Ashley T Haase
Journal:  Nature       Date:  2010-03-11       Impact factor: 49.962

3.  Immunization of the female genital tract with a DNA-based vaccine.

Authors:  J B Livingston; S Lu; H Robinson; D J Anderson
Journal:  Infect Immun       Date:  1998-01       Impact factor: 3.441

4.  Vaginal transmission of chimeric simian/human immunodeficiency viruses in rhesus macaques.

Authors:  Y Lu; P Brosio; M Lafaile; J Li; R G Collman; J Sodroski; C J Miller
Journal:  J Virol       Date:  1996-05       Impact factor: 5.103

Review 5.  Mucosal HIV transmission and vaccination strategies through oral compared with vaginal and rectal routes.

Authors:  Mingke Yu; Michael Vajdy
Journal:  Expert Opin Biol Ther       Date:  2010-08       Impact factor: 4.388

Review 6.  Herpes simplex virus and the chemokines that mediate the inflammation.

Authors:  D J J Carr; L Tomanek
Journal:  Curr Top Microbiol Immunol       Date:  2006       Impact factor: 4.291

Review 7.  Use of human mucosal tissue to study HIV-1 pathogenesis and evaluate HIV-1 prevention modalities.

Authors:  Charlene S Dezzutti; Florian Hladik
Journal:  Curr HIV/AIDS Rep       Date:  2013-03       Impact factor: 5.071

8.  Spontaneous cervicovaginal lesions and immune cell infiltrates in nonhuman primates.

Authors:  Carole E Harbison; Mary E Ellis; Susan V Westmoreland
Journal:  Toxicol Pathol       Date:  2013-02-20       Impact factor: 1.902

9.  Ex vivo comparison of microbicide efficacies for preventing HIV-1 genomic integration in intraepithelial vaginal cells.

Authors:  M Juliana McElrath; Lamar Ballweber; Andrew Terker; Allison Kreger; Polachai Sakchalathorn; Barry Robinson; Michael Fialkow; Gretchen Lentz; Florian Hladik
Journal:  Antimicrob Agents Chemother       Date:  2009-11-30       Impact factor: 5.191

Review 10.  HIV transmission.

Authors:  George M Shaw; Eric Hunter
Journal:  Cold Spring Harb Perspect Med       Date:  2012-11-01       Impact factor: 6.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.